GTSM:6523

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. More Details


Snowflake Analysis

Undervalued with excellent balance sheet.


Similar Companies

Share Price & News

How has Dr. Wu Skincare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 6523 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-1.0%

6523

-2.7%

TW Personal Products

-1.9%

TW Market


1 Year Return

-6.1%

6523

-3.0%

TW Personal Products

11.6%

TW Market

Return vs Industry: 6523 underperformed the TW Personal Products industry which returned -1.5% over the past year.

Return vs Market: 6523 underperformed the TW Market which returned 12.5% over the past year.


Shareholder returns

6523IndustryMarket
7 Day-1.0%-2.7%-1.9%
30 Day5.1%-6.8%1.5%
90 Day-5.7%-9.1%-0.02%
1 Year11.4%-6.1%0.9%-3.0%15.6%11.6%
3 Year-45.6%-55.6%37.7%27.3%31.1%16.6%
5 Year-50.5%-61.5%23.3%6.5%72.7%42.3%

Price Volatility Vs. Market

How volatile is Dr. Wu Skincare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Dr. Wu Skincare undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 6523 (NT$59.9) is trading below our estimate of fair value (NT$366.32)

Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 6523 is good value based on its PE Ratio (15.1x) compared to the TW Personal Products industry average (16.6x).

PE vs Market: 6523 is good value based on its PE Ratio (15.1x) compared to the TW market (18.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6523's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 6523 is good value based on its PB Ratio (2x) compared to the TW Personal Products industry average (2.2x).


Next Steps

Future Growth

How is Dr. Wu Skincare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.8%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Wu Skincare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Dr. Wu Skincare performed over the past 5 years?

-22.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 6523 has a large one-off gain of NT$49.2M impacting its June 30 2020 financial results.

Growing Profit Margin: 6523's current net profit margins (21.7%) are higher than last year (5.7%).


Past Earnings Growth Analysis

Earnings Trend: 6523's earnings have declined by 22% per year over the past 5 years.

Accelerating Growth: 6523's earnings growth over the past year (206.2%) exceeds its 5-year average (-22% per year).

Earnings vs Industry: 6523 earnings growth over the past year (206.2%) exceeded the Personal Products industry -3.2%.


Return on Equity

High ROE: 6523's Return on Equity (13.5%) is considered low.


Next Steps

Financial Health

How is Dr. Wu Skincare's financial position?


Financial Position Analysis

Short Term Liabilities: 6523's short term assets (NT$1.5B) exceed its short term liabilities (NT$300.8M).

Long Term Liabilities: 6523's short term assets (NT$1.5B) exceed its long term liabilities (NT$30.8M).


Debt to Equity History and Analysis

Debt Level: 6523's debt to equity ratio (0.01%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 6523's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 6523's debt is well covered by operating cash flow (319982.2%).

Interest Coverage: 6523 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Dr. Wu Skincare current dividend yield, its reliability and sustainability?

6.44%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 6523's dividend (6.44%) is higher than the bottom 25% of dividend payers in the TW market (2.25%).

High Dividend: 6523's dividend (6.44%) is in the top 25% of dividend payers in the TW market (5.51%)


Stability and Growth of Payments

Stable Dividend: 6523 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 6523's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (97.1%), 6523's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.3yrs

Average board tenure


CEO

Yirui Wu

no data

Tenure


Board Members

NamePositionTenureCompensationOwnership
Yirui Wu
Chairman & GMno datano datano data
Xuan Hu Xing
Administration Manager & Director2.5yrsno datano data
Tina Lin
Financial Manager & Representative Director0.25yrno datano data
Yiu-Pong Chan
Director6.5yrsno datano data
Ying-Chin Wu
Director15.5yrsno datano data
Chih-Hsiang Han
Independent Director5.33yrsno datano data
Hsin-Ju Wu
Independent Director5.33yrsno datano data
Chao-Sheng Chiang
Independent Director5.33yrsno datano data

5.3yrs

Average Tenure

Experienced Board: 6523's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Dr. Wu Skincare Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dr. Wu Skincare Co., Ltd.
  • Ticker: 6523
  • Exchange: GTSM
  • Founded: 2003
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: NT$2.698b
  • Shares outstanding: 45.05m
  • Website: https://www.drwu.com

Location

  • Dr. Wu Skincare Co., Ltd.
  • No.70, Nanjing East Road
  • 13th Floor
  • Taipei City
  • 104
  • Taiwan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6523GTSM (Taipei Exchange)YesOrdinary SharesTWTWDApr 2015

Biography

Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, moisturizers, and sunscreen and eye care products, as well ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/29 15:29
End of Day Share Price2020/10/29 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.